Almac are delighted to host this free event, which not only includes experts from industry and academia, but provides PhD students with the opportunity to showcase their research studies. Don't miss the opportunity to be involved in this prestigous event!
The main driver of the forum has been to bring scientists together who are involved in the design and scale up of chemical processes, and this year's forum is no exception. The event facilitates networking, addresses pertinent chemical challenges, fosters idea sharing and hosts new chemical trends.
The Nordic Process Chemistry Forum itself has a long history of attracting some of the most respected and innovative speakers in the world of chemistry, and we have already secured a fantastic line-up of industry speakers. Download our agenda to discover more.
Participation opportunities:
The main driver of the forum has been to bring scientists together who are involved in the design and scale up of chemical processes, and this year's forum is no exception. The event facilitates networking, addresses pertinent chemical challenges, fosters idea sharing and hosts new chemical trends.
The Nordic Process Chemistry Forum itself has a long history of attracting some of the most respected and innovative speakers in the world of chemistry, and we have already secured a fantastic line-up of industry speakers. Download our agenda to discover more.
Participation opportunities:
- Five Minutes of Fame: novel technology or exciting PhD research you want to shout about? We are seeking to showcase talent with an opportunity for you to present synthetic technologies within a 5-10 minute slot. These technology showcases will be judged by experts in the field and a prize will be awarded to the winner.
- Poster Presentations: we also have showcase opportunities via poster presentations. Download and complete the abstract submission form from our website to be considered.
- Exhibit: this is a cost-effective way to showcase the latest solutions you have to offer and raise your profile among the pharma community.
